Structural Heart Program
IHVI’s Structural Heart Disease Program is leading the way, bringing innovative, lifesaving techniques and devices to patients in the Washington, DC metropolitan region. The team specializes in finding alternatives to open-heart surgery for patients with heart valve disease, aortic stenosis, atrial fibrillation (AFib) and other structural abnormalities. Led by co-directors Drs. Matthew Sherwood and Eric Sarin, the structural heart disease program is pioneering catheter-based aortic valve treatments. Here are some of the ways Inova’s structural heart disease program is changing lives, including:
- TAVR – Aortic valve replacement can be a high-risk surgery for patients who have had heart surgery in the past, are of advanced age or have other risk factors. For these patients, an endovascular procedure called transfemoral aortic valve replacement (TAVR) offers an alternative.
- Emerging Technologies – In addition to TAVR, the Structural Heart Disease program offers the most promising techniques and devices for a wide range of structural heart patients. Notable examples include, stroke risk reduction for AFib patients with the Watchman® device; Transcatheter Mitral Valve Therapy (TMVT) with MitraClip; Transcatheter Mitral Valve Replacement (TMVR), applying TAVR principles to high-risk patients with mitral valve disease with the Intrepid™ TMVR system.
The Structural Heart Team applies a multidisciplinary approach to deciding how best to treat aortic valve disease in individual patients. The team works together to evaluate each patient and determine the best aortic valve replacement option. The program also offers dedicated coordinators and providers who guide patients through the preoperative and postoperative follow-up phases.